Vocci F - Search Results

1

Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.

Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL. Rosenthal RN, et al. Among authors: vocci f. Addiction. 2013 Dec;108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18. Addiction. 2013. PMID: 23919595 Free PMC article. Clinical Trial.

2

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.

Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ; PRO-814 Study Group. Rosenthal RN, et al. JAMA. 2016 Jul 19;316(3):282-90. doi: 10.1001/jama.2016.9382. JAMA. 2016. PMID: 27434441 Clinical Trial.

3

Medications development: successes and challenges.

Vocci F, Ling W. Vocci F, et al. Pharmacol Ther. 2005 Oct;108(1):94-108. doi: 10.1016/j.pharmthera.2005.06.010. Pharmacol Ther. 2005. PMID: 16083966 Review.

4

Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry.

Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ. Saxon AJ, et al. Addiction. 2018 Aug;113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1. Addiction. 2018. PMID: 29493836

5

Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, Vocci F. Elkashef A, et al. Among authors: vocci f. Addiction. 2005 Mar;100 Suppl 1:91-101. doi: 10.1111/j.1360-0443.2005.00986.x. Addiction. 2005. PMID: 15730353

6

Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.

Kampman KM, Leiderman D, Holmes T, LoCastro J, Bloch DA, Reid MS, Shoptaw S, Montgomery MA, Winhusen TM, Somoza EC, Ciraulo DA, Elkashef A, Vocci F. Kampman KM, et al. Among authors: vocci f. Addiction. 2005 Mar;100 Suppl 1:102-10. doi: 10.1111/j.1360-0443.2005.00987.x. Addiction. 2005. PMID: 15730354

7

The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.

Elkashef A, Rawson RA, Smith E, Pearce V, Flammino F, Campbell J, Donovick R, Gorodetzky C, Haning W, Mawhinney J, McCann M, Weis D, Williams L, Ling W, Vocci F. Elkashef A, et al. Among authors: vocci f. Addiction. 2007 Apr;102 Suppl 1:107-13. doi: 10.1111/j.1360-0443.2007.01779.x. Addiction. 2007. PMID: 17493059 Clinical Trial.

8

Bupropion for the treatment of methamphetamine dependence.

Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D. Elkashef AM, et al. Among authors: vocci f. Neuropsychopharmacology. 2008 Apr;33(5):1162-70. doi: 10.1038/sj.npp.1301481. Epub 2007 Jun 20. Neuropsychopharmacology. 2008. PMID: 17581531 Clinical Trial.

9

Unobserved "home" induction onto buprenorphine.

Lee JD, Vocci F, Fiellin DA. Lee JD, et al. Among authors: vocci f. J Addict Med. 2014 Sep-Oct;8(5):299-308. doi: 10.1097/ADM.0000000000000059. J Addict Med. 2014. PMID: 25254667 Review.

10

Clinical case conference: unobserved "home" induction onto buprenorphine.

Lee JD, McNeely J, Grossman E, Vocci F, Fiellin DA. Lee JD, et al. Among authors: vocci f. J Addict Med. 2014 Sep-Oct;8(5):309-14. doi: 10.1097/ADM.0000000000000060. J Addict Med. 2014. PMID: 25254668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page